Bodies of the Boehringer Ingelheim Stiftung.

Executive Committee.

As stipulated in the foundation's statutes, the Executive Committee is the legal representative of the foundation, and is responsible for the fulfilment of the foundation’s purpose and the administration of its assets. The Executive Committee is also the decision-making body regarding the awarding of grants. The foundation is jointly represented by two members of the Executive Committee, both in and out of court. All members of the Executive Committee work in an honorary capacity.

Executive Committee

• Christoph Boehringer (Chairman) – Entrepreneur, Ingelheim, Germany
• Prof. Dr Franz-Ulrich Hartl –Max Planck Institute of Biochemistry, Martinsried, Germany
• Dr Dr Michel Pairet – Member of the Shareholders' Committee, C.H. Boehringer Sohn AG & Co. KG, Ingelheim, Germany
• Prof. Dr Jan-Michael Peters – Research Institute of Molecular Pathology (IMP), Vienna, Austria

Honorary Chairman of the Executive Committee

• Otto Boehringer – Mainz, Germany

Scientific Advisory Board.

The Scientific Advisory Board supports and advises the Executive Committee on science-related matters. All members work in an honorary capacity. Their expertise contributes decisively to the development of the foundation’s funding portfolio: For instance, the members of the Scientific Advisory Board are involved in periodical evaluations of funding programmes and initiatives. They also e.g. scrutinize and discuss applications submitted to the foundation's funding programmes based on the analysis of external peer-reviewers, and provide recommendations to the Executive Committee with respect to approval or rejection.

• Prof. Dr Ivan Dikic – Institute of Biochemistry II, Goethe University Medical Faculty, Frankfurt am Main, Germany
• Dr Dr Michel Pairet – Member of the Shareholders' Committee, C.H. Boehringer Sohn AG & Co. KG, Ingelheim, Germany
• Prof. Dr Britta Siegmund – Division of Gastroenterology, Infectiology und Rheumatology, Charité – Universitätsmedizin, Berlin, Germany
• Prof. Dr Herbert Waldmann (Chairman) – Max Planck Institute of Molecular Physiology, Dortmund, Germany

Managing Directors.

The Managing Directors are appointed by the foundation's Executive Committee. Together with their staff, they conduct the day-to-day business of the Boehringer Ingelheim Stiftung. The current Managing Directors are

• Dr Stephan Formella – Managing Director Science & Research
• Marc Wittstock – Managing Director Finance & Administration

The foundation's offices are located in Mainz, Germany.